NCT00268970 - Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

September 30, 2009

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Satraplatin in combination with Paclitaxel

Paclitaxel 200 mg/m2 IV over 3 hours on day 1. Satraplatin 60 mg/m2 administered by mouth once daily for 5 consecutive days (days 1-5). Satraplatin will be administered within 2 hours following paclitaxel infusion on day 1. Subsequent doses on days 2-5 will be taken at approximately 24 hour intervals.

Trial Locations (1)

37203

Sarah Cannon Research Institute, Nashville